共 50 条
Towards 50 years of platelet function analyser (PFA) testing
被引:11
|作者:
Favaloro, Emmanuel J.
[1
,2
,3
]
Pasalic, Leonardo
[1
,2
,4
]
Lippi, Giuseppe
[5
,6
]
机构:
[1] NSW Hlth Pathol, Inst Clin Pathol & Med Res ICPMR, Haematol, Westmead, NSW 2145, Australia
[2] Sydney Ctr Thrombosis & Haemostasis, Westmead, NSW, Australia
[3] Charles Sturt Univ, Fac Sci & Hlth, Wagga Wagga, NSW, Australia
[4] Univ Sydney, Westmead Clin Sch, Westmead, NSW, Australia
[5] Univ Verona, Sect Clin Biochem, Verona, Italy
[6] Univ Verona, Sch Med, Verona, Italy
关键词:
in vitro bleeding time;
PFA-100;
PFA-200;
platelet function analyser;
LIGHT TRANSMITTANCE AGGREGOMETRY;
VON-WILLEBRAND-DISORDER;
BLEEDING-TIME PFA-100;
ABO BLOOD-GROUP;
IN-VITRO;
LABORATORY DIAGNOSIS;
CLINICAL UTILITY;
CLOSURE TIMES;
COAGULATION;
PARAMETERS;
D O I:
10.1515/cclm-2022-0666
中图分类号:
R446 [实验室诊断];
R-33 [实验医学、医学实验];
学科分类号:
1001 ;
摘要:
The platelet function analyser (PFA) is a prevalent platelet function screening instrument, and comes in two models-the original PFA-100 and the contemporary PFA-200. The instruments have 'identical' output, being a 'closure time' (CT). Moreover, normal reference ranges provided by the manufacturer, for the specific test cartridges, are the same for both models. There are three different types of test cartridge: collagen/epinephrine (C/Epi), collagen/adenosine diphosphate (C/ADP), and "Innovance PFA P2Y" (only available in certain geographical locations). The PFA-100 was released in the mid 1990s, and so is approaching 50 years of age. The PFA-200, released in some locations in the mid 2010s, is destined to eventually replace the PFA-100, but is not yet available in the USA. The test system is highly sensitive to von Willebrand disease (VWD; C/Epi and C/ADP) and to aspirin therapy (C/Epi only), but only has moderate sensitivity to defects in platelet function and/or deficiencies in platelet number. Accordingly, recommendations for use for screening platelet function vary according to user experience. Some workers have alternatively used the PFA to assess thrombosis risk or pre-operative bleeding risk. In this review, we provide an overview of the history of PFA, and summarise its current clinical utility.
引用
收藏
页码:851 / 860
页数:10
相关论文